Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2026Heart RhythmOpen Access

Modelled rhythm-guided pill-in-the-pocket anticoagulation projects ~91% less OAC exposure while maintaining high AF coverage.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does a rhythm-guided pill-in-the-pocket anticoagulation strategy reduce OAC exposure while adequately covering time in AF in patients post-cryoballoon ablation?

Population

Patients with atrial fibrillation post-cryoballoon ablation with CHA2DS2-VASc ≥1

Comparison

Modelled rhythm-guided pill-in-the-pocket oral… vs Continuous lifelong oral anticoagulation

Design

Cohort

Key result

A modelled rhythm-guided pill-in-the-pocket anticoagulation strategy with a ≥1-hour AF threshold and 30-day window covered 97.5% of time in AF while reducing OAC exposure by 90.8%.

Authors

AGAndré Briosa e GalaJMJens MaurhoferSISalik ur Rehman Iqbal

Discussion

Loading...

Member takes

Overview

May support prospective trials of intermittent OAC post-ablation; leaves open whether 90% exposure reduction preserves stroke prevention.

Key Points

  • To characterize long-term atrial fibrillation burden after cryoballoon ablation and model the efficacy and coverage of rhythm-guided, intermittent oral anticoagulation.
  • Conducted a post-hoc analysis of the COMPARE-CRYO trial.
  • Modeled rhythm-guided oral anticoagulation triggers based on daily atrial fibrillation burdens of ≥6 minutes, ≥1 hour, ≥5.5 hours, and ≥23.5 hours using variable treatment window durations (14 or 30 days).
  • A restart-and-continue strategy triggered by atrial fibrillation lasting ≥6 minutes led to anticoagulation use during 32% of follow-up.
  • Pill-in-the-pocket strategies using fixed 14-day or 30-day windows reduced overall oral anticoagulation exposure by 90.8% to 99.4%.
  • A threshold of ≥1 hour combined with a 30-day treatment window provided the best balance, covering 97.5% of time in atrial fibrillation while decreasing anticoagulation exposure by 90.8%.

Study Design

Type

Observational

Structured PICO

Does a rhythm-guided pill-in-the-pocket anticoagulation strategy reduce OAC exposure while adequately covering time in AF in patients post-cryoballoon ablation?

P
Population
Patients with atrial fibrillation post-cryoballoon ablation with CHA2DS2-VASc ≥1
E
Exposure
Modelled rhythm-guided pill-in-the-pocket oral anticoagulation (OAC) strategies triggered by daily AF burden (≥6 minutes, ≥1 hour, ≥5.5 hours, and ≥23.5 hours) with fixed OAC windows (14 or 30 days)
C
Comparator
Continuous lifelong oral anticoagulation (standard of care)
O
Outcome
OAC exposure time and time-in-AF coveragesurrogate

A modelled rhythm-guided pill-in-the-pocket anticoagulation strategy post-AF ablation could substantially reduce OAC exposure while maintaining high coverage during AF episodes.

Limitations

  • These strategies require prospective evaluation of clinical outcomes.
  • Requires prospective evaluation of clinical outcomes

Cite This Study

Gala et al. (2026) conducted an observational in Atrial fibrillation post-cryoballoon ablation. Modelled rhythm-guided pill-in-the-pocket oral anticoagulation vs. Restart-and-continue strategy was evaluated on Reduction in oral anticoagulation exposure and time-in-AF coverage. A modelled rhythm-guided pill-in-the-pocket anticoagulation strategy with a ≥1-hour AF threshold and 30-day window covered 97.5% of time in AF while reducing OAC exposure by 90.8%.

synapsesocial.com/papers/6aacf5ed0c46fbdff987dd07https://doi.org/10.1016/j.hrthm.2026.09.005
View Full Paper
Ask AI
Bookmark
Share